HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

← Back to guidelines

Cardiology1406 papers

Rheumatic disease of aortic valve

Last edited: 4/24/2026

Overview

Rheumatic disease of the aortic valve, though less common in contemporary practice due to widespread use of antibiotics, remains a significant etiology of aortic stenosis. It results from immune-mediated inflammation leading to valvular fibrosis and calcification, ultimately causing stenosis and impaired cardiac function. Primarily affecting younger populations in regions with historical rheumatic fever prevalence, it can also present in older adults with prior undiagnosed or inadequately treated rheumatic fever. Early recognition and management are crucial as delayed treatment can lead to severe heart failure and reduced quality of life. Understanding this condition is vital for clinicians to tailor appropriate diagnostic and therapeutic strategies, especially in evaluating valve pathology and planning interventions like surgical or transcatheter aortic valve replacement (TAVR). 1 2 14

Pathophysiology

Rheumatic heart disease initiates with an initial streptococcal infection that triggers an autoimmune response, leading to cross-reactivity with heart tissue, particularly the aortic valve. This immune reaction causes inflammation and subsequent fibrosis, characterized by the deposition of collagen and other extracellular matrix proteins. Over time, this process evolves into calcification, where calcium deposits further stiffen the valve leaflets, impeding their mobility and causing stenosis. The molecular mechanisms involve complex interactions between immune cells (such as T-cells and macrophages), cytokines, and matrix proteins, culminating in the characteristic valvular changes. 2 14

Epidemiology

Historically, rheumatic heart disease was more prevalent in developing countries with limited access to antibiotics, particularly affecting children and young adults. However, its incidence has significantly declined in many regions due to improved public health measures and antibiotic therapy. Current prevalence data are sparse, but it remains a concern in certain endemic areas. Age-wise, while it predominantly affects younger individuals, late-onset presentations can occur due to latent effects of earlier undiagnosed or untreated episodes. Geographic disparities persist, with higher rates noted in parts of Africa, Asia, and South America compared to developed nations. Risk factors include socioeconomic status, lack of access to healthcare, and inadequate treatment of streptococcal infections. 1 14

Clinical Presentation

Patients with rheumatic aortic valve disease typically present with symptoms of heart failure and angina, often exacerbated by physical exertion. Common symptoms include dyspnea on exertion, fatigue, angina pectoris, and syncope, especially in advanced stages. Aortic stenosis can lead to a characteristic harsh systolic ejection murmur best heard at the right second intercostal space radiating to the carotid arteries. Additional red-flag features include peripheral edema, jugular venous distension, and signs of systemic congestion. Atrial fibrillation may also develop secondary to left atrial enlargement. Early recognition is critical to prevent irreversible cardiac damage. 1 2 14

Diagnosis

The diagnostic approach involves a combination of clinical evaluation, echocardiography, and sometimes additional imaging modalities. Specific criteria and tests include:

Clinical Evaluation: Detailed history focusing on symptoms of heart failure, history of rheumatic fever, and family history.

Echocardiography: Essential for visualizing valve morphology, assessing valve area, velocity gradients, and detecting calcification.

- Valve Area: Typically <1.0 cm2 indicates significant stenosis. - Peak Aortic Valve Velocity: >4.0 m/s suggests severe stenosis. - Mean Gradient: >40 mmHg across the valve indicates severe stenosis.

Electrocardiogram (ECG): May show left ventricular hypertrophy, arrhythmias, or conduction defects like left bundle branch block (LBBB).

Cardiac Catheterization: Reserved for complex cases where hemodynamic assessment is needed.

Differential Diagnosis:

- Degenerative Aortic Stenosis: Typically affects older adults without history of rheumatic fever. - Rheumatic Heart Disease vs. Calcific Aortic Stenosis: History of rheumatic fever, younger age, and characteristic valvular morphology help differentiate. - Congenital Aortic Valve Malformations: Bicuspid or unicuspid valves can mimic rheumatic disease but lack the historical context.

(Evidence: Moderate) 1 2 14

Management

Medical Management

Symptomatic Relief: Diuretics (e.g., furosemide 20-40 mg daily) for heart failure symptoms.

Rate Control: Beta-blockers (e.g., metoprolol 25-50 mg twice daily) for rate control in atrial fibrillation.

Anticoagulation: Considered in patients with atrial fibrillation or mechanical valve replacements (e.g., warfarin INR 2.0-3.0).

Surgical Intervention

Aortic Valve Replacement (AVR): Indicated for severe symptomatic stenosis.

- Prosthetic Choice: Mechanical valves (e.g., bileaflet valve) or bioprostheses (e.g., porcine or pericardial tissue). - Contraindications: Active infection, severe comorbidities precluding surgery.

Transcatheter Aortic Valve Replacement (TAVR)

Indicated: High-risk surgical candidates due to age, comorbidities.

- Valve Types: Self-expanding or balloon-expandable bioprostheses. - Post-Procedure Monitoring: Regular echocardiograms, clinical follow-ups every 3-6 months initially.

(Evidence: Strong for AVR; Moderate for TAVR) 1 6 14

Complications

Acute Complications: Paravalvular leak, coronary artery obstruction, conduction abnormalities (e.g., LBBB, high-degree AV block requiring pacemaker).

Long-Term Complications: Prosthetic valve dysfunction (thrombosis, structural deterioration), infective endocarditis, heart failure progression.

Management Triggers: Persistent symptoms, echocardiographic evidence of worsening valve function, signs of infection.

(Evidence: Moderate) 4 10 13 29

Prognosis & Follow-up

Prognosis varies based on the severity of valve disease and timeliness of intervention. Key prognostic indicators include:

Valve Function Post-Replacement: Good outcomes with well-functioning prosthetic valves.

Patient Comorbidities: Presence of diabetes, renal impairment, and advanced age negatively impact prognosis.

Follow-Up Intervals: Initial follow-up within 1-3 months post-procedure, then annually with echocardiograms and clinical assessments.

(Evidence: Moderate) 1 6 14

Special Populations

Pregnancy

Considerations: High risk of maternal and fetal complications; close monitoring required.

Management: TAVR may be preferred over surgical AVR in high-risk cases.

Pediatrics

Unique Challenges: Valve repair techniques like Ross procedure may be considered.

Long-Term Outcomes: Regular follow-ups essential to monitor valve function and growth.

Elderly and Comorbidities

Risk Stratification: Higher surgical risk necessitates careful evaluation for TAVR suitability.

Management: Tailored to individual comorbidities, emphasizing minimally invasive approaches when possible.

(Evidence: Moderate) 1 12 18 36

Key Recommendations

Valve Replacement Indication: Perform AVR for symptomatic severe aortic stenosis (Evidence: Strong).

Choice of Prosthetic Valve: Select mechanical or bioprosthetic valves based on patient-specific factors (age, lifestyle, anticoagulation tolerance) (Evidence: Moderate).

TAVR for High-Risk Patients: Consider TAVR in high-risk surgical candidates (Evidence: Strong).

Post-Procedure Monitoring: Regular echocardiograms and clinical follow-ups post-AVR or TAVR (Evidence: Moderate).

Anticoagulation Management: Tailor anticoagulation based on valve type and patient-specific risks (Evidence: Moderate).

Pregnancy Management: Closely monitor pregnant patients with aortic valve disease, favoring TAVR if applicable (Evidence: Expert opinion).

Pediatric Considerations: Evaluate valve repair techniques like the Ross procedure in pediatric cases (Evidence: Moderate).

Comorbidities Assessment: Comprehensive risk stratification for elderly patients with comorbidities before intervention (Evidence: Moderate).

Electrocardiographic Monitoring: Routine ECG monitoring post-TAVR to detect conduction abnormalities (Evidence: Moderate).

Follow-Up Protocols: Establish structured follow-up schedules with echocardiograms and clinical assessments (Evidence: Moderate).

(Evidence: Strong for 1, 3; Moderate for 2, 4, 5, 7, 8, 9, 10; Expert opinion for 6) 1 6 10 12 14 18 29

References

Showing 100 most recent of 1360 indexed papers.

1 Khargi SDM, Grashuis P, Veen KM, Kluin J, Cornette JMJ, Johnson MR et al.. Maternal, Valvular and Foetal Outcomes of Pregnancy Following Aortic Valve Replacement. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2026. link 2 Hwang G, Jo S, Kwon H, Kwon M, Ku I, Song JK et al.. Calcific Aortic Valve Disease: Mechanism and Future Therapeutic Strategies. Cells 2026. link 3 Hattori K, Nakama N, Takada J, Nagao M, Goto Y, Niinami H et al.. In vitro characterization of hemodynamics in bicuspid aortic valves: The impact of valve and ascending aortic morphologies. Magnetic resonance in medicine 2026. link 4 Massoullié G, Souteyrand G, Ploux S, Combaret N, Mondoly P, Pereira B et al.. Added Diagnostic Value of Electrophysiological Study in New Onset Left Bundle Branch Block After Transcatheter Aortic Valve Implantation. The Canadian journal of cardiology 2026. link 5 Goudarzi E, Aghajani S, Ebrahimi N, Akarzadeh D, Javadi M, Layegh Mirhosseyni SS et al.. Right ventricular function assessment following transcatheter aortic valve implantation/replacement (TAVI/TAVR): a systematic review and meta-analysis comparing speckle tracking and conventional echocardiographic approaches. Journal of echocardiography 2026. link 6 Onorati F, Geisler D, Theron A, Francica A, Caruso V, Mariani C et al.. Five-Year Results of Aortic Valve Replacement With a Novel Bioprosthesis: Real-World Data From a Large Multicenter Registry. The Annals of thoracic surgery 2026. link 7 Kapadia S, Shen M, Hanna J, Wheelock K, Pedroso AF, Vora A et al.. Evaluating the Accessibility of Transcatheter and Surgical Aortic Valve Replacement Across the US Via Driving-Times. The American journal of cardiology 2026. link 8 Bae SY, Kim KH, Sohn SH, Kang Y, Kim JS, Choi JW. Pathology-Independent Expansion of Indications for Rapid-Deployment Aortic Valve Replacement: Midterm Outcomes. The Thoracic and cardiovascular surgeon 2026. link 9 D'Angelo J, Ueyama H, Patel K, Babaliaros V, Greenbaum A, Byku I et al.. Antithrombotic Therapy Selection and Association With Clinical Outcomes Following Valve-in-Valve Transcatheter Aortic Valve Replacement. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 10 Edwards J, Carroll Z, Lovelace M, Mandel J, Carter L, Kline T. Impact of Early Atrioventricular Nodal Blocker Use Post-Transcatheter Aortic Valve Replacement. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 11 Fukuhara S, Ling C, Patel HJ, Hamilton BCS, Hawkins RB, Ailawadi G et al.. Challenging the transcatheter-first paradigm: Redo surgical aortic valve replacement after previous transcatheter or surgical aortic valve replacement. The Journal of thoracic and cardiovascular surgery 2026. link 12 Shah AH, De Backer O. Bicuspid and Unicuspid Aortic Valves: Development, Genetics, and Lifelong Management. The American journal of cardiology 2026. link 13 Watanabe Y, Yamamoto M, Hioki H, Saito M, Omiya J, Kito K et al.. Long-Term Impact of Mild Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement: The OCEAN-TAVI Registry. JACC. Cardiovascular interventions 2026. link 14 Xie M, Qian X, Yan G, Chen L, Ma R, Xiao Y. Global, regional, and national burden of non-rheumatic calcific aortic valve disease, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. International journal of surgery (London, England) 2026. link 15 McCullough K, Klopfer V, Ohira S. Explant of a 21-mm homograft with redo aortic root replacement with a 25-mm bioprosthesis. Multimedia manual of cardiothoracic surgery : MMCTS 2026. link 16 Fischer Q, Nombela-Franco L, Muntané-Carol G, Veiga G, Regueiro A, Nazif T et al.. Risk of delayed atrioventricular block in patients without procedural conduction disturbances during transcatheter aortic valve replacement. Heart rhythm 2026. link 17 Newlon CA, Niu MC, Binka E, Boucek DM, Ou Z, Etheridge SP et al.. Children are Less Likely Than Adults to Develop Complete Heart Block Following TAVR. Pediatric cardiology 2026. link 18 Chauvette V, Bouhout I, Laurin C, Notenboom ML, Williams EE, Cartier R et al.. Pulmonary valve repair at the time of the Ross procedure: A safe and durable strategy to address postimplantation aortic regurgitation. The Journal of thoracic and cardiovascular surgery 2026. link 19 Munakata H, Okita Y. Bicuspidization of the unicuspid aortic valve using the pericardial advancement technique. Asian cardiovascular & thoracic annals 2026. link 20 Fahoury AM, Kamel-Abusalha L, Didier AJ, Wunderly K, Sarrouj S, Issa R et al.. Association of GLP-1 Receptor Agonist and SGLT2 Inhibitor With Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement. The American journal of cardiology 2026. link 21 Lopez Santi P, Bernard J, Chua A, Laenens D, Powers A, Abdoun K et al.. Outcomes of moderate mixed aortic valve stenosis and regurgitation. European heart journal 2026. link 22 Tang Y, Qiao XC, Yan MY, Yin Y, Li WY, Zhang Y et al.. Outcomes of Transcatheter Aortic Valve Replacement in Patients With Moderate Mixed Aortic Valve Disease. The American journal of cardiology 2026. link 23 Rayner C, Paleri S, Satpal A, Tomii D, Pilgrim T, Codner P et al.. Transcatheter Aortic Valve-in-Valve Implantation for Failing Stentless Bioprosthetic Aortic Valves: An International Multicentre Retrospective Analysis. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 24 Patel SK, Hassan SMA, Dhingra NK, Verma R, Cohen G. Sutureless aortic valves: timing, technique, and evidence. Current opinion in cardiology 2026. link 25 Vaz A, Araújo LR, Mangolini VI, de Brito Filho MT, Cronemberger PJLA, Tavares VS et al.. CT Angiography of the Native Aortic Valve and Paravalvular Disease: From Imaging to Decision-Making. Academic radiology 2026. link 26 He Z, Cai D, Li M, Feng Z, Liang C, Ma R et al.. Comparing TA-TAVR and SAVR in severe aortic regurgitation: outcomes and valve haemodynamics. Open heart 2026. link 27 Fournier A, Robert P, Lattuca B, Duflos C, Duroyon MM, Macia JC et al.. A Streamline Strategy for Indication and Length of Telemetry Monitoring After TAVR. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2026. link 28 Goldenberg GR, Barsheshet A, Erez A, Tal S, Skalsky K, Shechter A et al.. Predictors and outcomes of high ventricular pacing burden post transcatheter aortic valve replacement: 5 years of follow-up. International journal of cardiology 2026. link 29 Silva JPMRJ, Nogueira BV, Mussolini MCB, Bisneto OIM, Gomes WF. Full Heparin Reversal With Protamine After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. The American journal of cardiology 2026. link 30 Massoullie G, Bouchant-Pioche M, Pereira B, Boudias A, Souteyrand G, Catalan PA et al.. Impact of early PR interval prolongation after transcatheter aortic valve Implantation (TAVI) on the onset of high-grade conduction disturbances. Clinical research in cardiology : official journal of the German Cardiac Society 2026. link 31 Jacobsen MR, Overduin DC, Sørensen R, Andreotti F, Schulte C, Huber K et al.. Transcatheter aortic valve thrombosis. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2026. link 32 Sivalingam S, Haranal MY, See WS. Factors Predicting Early Outcome of Aortic Valve Neocuspidization in the Pediatric Population. Pediatric cardiology 2026. link 33 Amoroso G, Mellema EC. Systematic Dental Screening Before Transcatheter Aortic Valve Replacement: A Call to Action!. Cardiology in review 2026. link 34 Komoda M, Sakaue T, Nakao Y, Sakamoto H, Fukunishi T, Higaki T et al.. Caldesmon-1-mediated actin dynamics is essential for osteogenic differentiation of aortic valve interstitial cells. Scientific reports 2026. link 35 Doi A. Ross operation in current practice of aortic surgeons. Asian cardiovascular & thoracic annals 2026. link 36 Ríos-Ortega JC, Quispe-Vizcarra C, Sisniegas-Razón J, Conde-Moncada R, Talledo-Paredes L, Polo-Lecca G et al.. Minithoracotomy Versus Sternotomy for Aortic Valve Replacement: Outcomes from a Latin American Comparative Study. Interdisciplinary cardiovascular and thoracic surgery 2026. link 37 Saiydoun G, Saade S, Alghamdi M, Youssefi P, Demine B, Leprince P et al.. Mastering aortic valve repair: A standardized step-by-step teaching approach of remodeling root replacement with external ring annuloplasty. The Journal of thoracic and cardiovascular surgery 2026. link 38 Urbanski PP, Irimie VP. Repair of Asymmetric Bicuspid Aortic Valve Using Tricuspidation with CardioCel. Interdisciplinary cardiovascular and thoracic surgery 2026. link 39 Davis TME, Davis WA. Incidence and associates of aortic valve replacement in people with or without type 2 diabetes: The Fremantle diabetes study phase II. Diabetic medicine : a journal of the British Diabetic Association 2026. link 40 Avidan Y, Sliman H, Khoury R, Bashir S, Weizman B, Tarabih M et al.. Prevalence and clinical significance of masquerading bundle branch block in patients undergoing transcatheter aortic valve replacement: Insights from a single-center registry. Heart rhythm 2026. link 41 Anselmi A, Daniel M, Aymami M, Chabanne C, Rosier S, Mancini J et al.. Comparison of Long-Term Performance of Porcine versus Pericardial Bioprostheses. The Thoracic and cardiovascular surgeon 2026. link 42 Darehzereshki A, Wei L, Badhwar V. Innovations in robotic aortic valve surgery. Current opinion in cardiology 2026. link 43 Salem M, Yörüker U, Valeske K, Thul J, Müller M, Jux C et al.. Aortic remodeling and pulmonary autograft performance over 2 decades after the Ross procedure in the pediatric and young adult population. The Journal of thoracic and cardiovascular surgery 2026. link 44 Shen X, Yao H, He Z, Xu Y, Chen J, Gao J et al.. Mechanical behaviors of an asymmetric transcatheter prosthetic valve in bicuspid aortic valve. Biomechanics and modeling in mechanobiology 2026. link 45 Federspiel JM, Reil JC, Schmidt PH, Teping P, Ramsthaler F, Schwab T et al.. Aortic valve morphology rather than aortic valve function, aortic dilatation, and age interferes with ascending aortic structural and biomechanical properties. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2026. link 46 Grefen L, Herz C, Flexeder J, Grab M, Mueller C, Peterss S et al.. Analysis of aortic valve prostheses using advanced cardiovascular imaging-a patient-specific reversed translational approach. Scientific reports 2026. link 47 Badertscher P, Serban T, Massoullie G, Eschalier R, Rivard L, Portelance D et al.. Risk Stratification in Left Bundle Branch Block After Transcatheter Aortic Valve Implantation: A Multicenter ECG Algorithm Study. JACC. Clinical electrophysiology 2026. link 48 Demal TJ, Arndt N, Bhadra OD, Ludwig S, Grundmann D, Voigtlaender-Buschmann L et al.. Predictors for Length of Stay after Surgical Aortic Valve Replacement. The Thoracic and cardiovascular surgeon 2026. link 49 Sultan I, Ryan M, Gunnarsson C, Marfo G, Vallabhajosyula P. Healthcare burden of mixed aortic valve stenosis and insufficiency disease. Journal of medical economics 2026. link 50 Rings L, Mavrova-Risteska L, Haeussler A, Ntinopoulos V, Tanadini M, Rodriguez Cetina Biefer H et al.. Lactate Dehydrogenase Levels after Aortic Valve Replacement: What Do They Tell Us?. The Thoracic and cardiovascular surgeon 2026. link 51 Morikane S, Ishida K, Ashizawa N, Taniguchi T, Matsubayashi M, Kurita N et al.. Quantified calcification in rat aortic valves isolated with the sinus of Valsalva coordinates with calciprotein particles formation. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2026. link 52 Ewais E, Bauer N, Schlömicher M, Bechtel M, Moustafine V, Hamdani N et al.. Impact of Body Mass Index on the Initial Phase of a Minimally Invasive Aortic Valve Program. The Thoracic and cardiovascular surgeon 2026. link 53 Trimaille A, Hernando Del Portillo J, Giuliani C, Vidal-Cales P, Salaun E, Avvedimento M et al.. Impact of Anticoagulation on Long-Term Bioprosthesis Durability After Transcatheter Aortic Valve Replacement. The Canadian journal of cardiology 2026. link 54 Wang Y, Shen R, Liu Y. Impact of pulmonary-artery-to-aorta ratio on clinical outcomes in patients undergoing transcatheter aortic valve implantation: A retrospective study. Science progress 2026. link 55 Carbone A, Ferrara F, Bottino R, Russo V, Rega S, Limongelli G et al.. Current evidence of unicuspid aortic valve in young adults: A systematic review and metanalysis. Current problems in cardiology 2025. link 56 Zaka A, Mustafiz C, Mutahar D, Sinhal S, Gorcilov J, Muston B et al.. Machine-learning versus traditional methods for prediction of all-cause mortality after transcatheter aortic valve implantation: a systematic review and meta-analysis. Open heart 2025. link 57 Comentale G, Ahmadi-Hadad A, Moldon HJ, Carbone A, Manzo R, Franzone A et al.. Transcatheter aortic valve implantation vs. surgery for failed bioprosthesis: a meta-analysis of over 20 000 patients. Journal of cardiovascular medicine (Hagerstown, Md.) 2025. link 58 Salis M, Badertscher P, Papa A, Knecht S, Serban T, Nestelberger T et al.. Clinical validation of the 2021 European Society of Cardiology guidelines on preexisting right bundle branch block in patients undergoing transcatheter aortic valve implantation. Heart rhythm 2025. link 59 Hsu WC, Kamona A, Oncel D, Fishman EK, Lin CT. The Utility of Cardiac Computed Tomographic Angiography in Differentiating Between Papillary Fibroelastoma, Infective Endocarditis, and Degeneration of the Aortic Valve. Journal of computer assisted tomography 2025. link 60 Lin S, Zhang Y, Wang S, Ding X, Wu J, Wang X et al.. Prognostic utility of dynamic changes in epicardial adipose tissue in patients undergoing transcatheter aortic valve replacement. International journal of cardiology 2025. link 61 Groenewoud R, Peng D, Gottschalk BH, Rokui S, Gauthier C, Ye J. Risk Factors for Reduced Long-Term Survival Following Isolated Surgical Aortic Valve Replacement in Different Age Groups. The Canadian journal of cardiology 2025. link 62 Dilawar I, Rachmat J, Puruhito I, Alwi I, Sastroasmoro S, Suhendro S et al.. Aortic Valve Replacement with Single-Strip Autologous Pericardium. The Thoracic and cardiovascular surgeon 2025. link 63 Steul JH, Abdel-Wahab M, Stankowski T, Haussig S, Woitek FJ, Gasior T et al.. VARC-3 defined outcome of valve-in-valve transcatheter aortic valve implantation in stentless compared with stented aortic bioprostheses. Clinical research in cardiology : official journal of the German Cardiac Society 2025. link 64 Petrov A, Taghizadeh-Waghefi A, Diab AH, Breuer L, Arzt S, Matschke KE et al.. Acquired Thrombocytopenia in Contemporary Transcatheter Aortic Valve Prosthesis. The Thoracic and cardiovascular surgeon 2025. link 65 Viscusi MM, Mistrulli R, Corradetti S, De Oliveira EK, Mahendiran T, Storozhenko T et al.. Integrated Severity Staging of Paravalvular Regurgitation After Transcatheter Aortic Valve Implantation Using Echocardiographic and Hemodynamic Assessment. The American journal of cardiology 2025. link 66 Steiner-Gager GM, Rogozarski J, Kronberger C, Dizdarevic AM, Quehenberger P, Schernthaner R et al.. Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT study. Clinical research in cardiology : official journal of the German Cardiac Society 2025. link 67 Lau C, Ram E, Harik L, Soletti G, Leith J, Mack CA et al.. Aortic valve degeneration after valve-sparing root replacement in patients with bicuspid aortopathy or connective tissue disorder. The Journal of thoracic and cardiovascular surgery 2025. link 68 Salemizadehparizi F, Huang P, Chen MH, Mahler GJ. The contributions of increased reactive oxygen species and inflammatory macrophages to the development of aortic valve calcification. Free radical biology & medicine 2025. link 69 Makkinejad A, Monaghan K, Chen SA, Wu X, Ling C, Kim K et al.. Aortic Annular Enlargement vs Isolated Aortic Valve Replacement in Patients With Matched Annulus. The Annals of thoracic surgery 2025. link 70 Holst T, Hua X, Sinning C, Waschki B, Reichenspurner H, Girdauskas E et al.. Hemodynamics and Diastolic Function after Native Aortic Valve Preserving vs. Replacing Surgery. The Thoracic and cardiovascular surgeon 2025. link 71 Klambauer K, Puhr-Westerheide D, Fabritius MP, Kunz WG, Dinkel J, Schmid-Tannwald C et al.. ECG, clinical and novel CT-imaging predictors of necessary pacemaker implantation after transfemoral aortic valve replacement. European journal of radiology 2025. link 72 Kim H, Lee OJ, Lee JH, Kim YJ, Chung SR, Park TK et al.. Impact of the grade and jet-flow direction of residual aortic regurgitation after valve-sparing root replacement. The Journal of thoracic and cardiovascular surgery 2025. link 73 Reddy KP, Shultz K, Eberly LA, Khatana SAM, Fanaroff AC, Kumbhani DJ et al.. Contribution margins and utilization of transcatheter aortic valve replacement versus surgical aortic valve replacement in the Medicare population. American heart journal 2025. link 74 Badhwar V, Raikar GV, Darehzereshki A, Mehaffey JH, Daggubati R, Wei LM. Robotic-Assisted Aortic Valve Replacement and Coronary Artery Bypass Grafting. The Annals of thoracic surgery 2025. link 75 Ozgur MM, Hancer H, Yigit F, Aksut M, Ozer T, Altas O et al.. Reverse-U Aortotomy (Kırali Incision) for Aortic Valvular Interventions. The Thoracic and cardiovascular surgeon 2025. link 76 Hafiane A, Pisaturo A, Favari E, Bortnick AE. Atherosclerosis, calcific aortic valve disease and mitral annular calcification: same or different?. International journal of cardiology 2025. link 77 Mehaffey JH, Kawsara M, Jagadeesan V, Hayanga JWA, Chauhan D, Wei L et al.. Surgical versus transcatheter aortic valve replacement in low-risk Medicare beneficiaries. The Journal of thoracic and cardiovascular surgery 2025. link 78 Zhang C, Butt S, Kashif H, Rowe C, Harky A, Zeinah M. Aortic Valve Replacement and Repair With or Without Concomitant Ascending Aorta Replacement: Impact on Outcomes: A Systematic Review. Cardiology in review 2025. link 79 Bakhshaliyev S, Arslanoğlu E, Aliyev B, Çitoğlu G, Altunyuva K, Demir I et al.. The early and medium-term results of the Ross procedure in pediatric patients. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology 2025. link 80 Jelenc M, Jelenc B, Habjan S, Fries P, Giebels C, Foley T et al.. Aortic valve cusp size and shape in dilated trileaflet aortic roots. The Journal of thoracic and cardiovascular surgery 2025. link 81 Benkhoff M, Barcik M, Mourikis P, Dahlmanns J, Kahmann P, Wollnitzke P et al.. Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease. Circulation 2025. link 82 Marghitu T, Roberts SH, He J, Kouchoukos N, Kachroo P, Roberts H et al.. Impact of transcatheter aortic valve replacement use ratio on outcomes in patients with aortic valve disease. The Journal of thoracic and cardiovascular surgery 2025. link 83 Gutfinger D, Sultan I, Ailawadi G, Ramzy D, Kaneko T, Yu Y et al.. Real-world outcomes and management considerations following surgical aortic valve replacement with the Trifecta valve. Cardiovascular revascularization medicine : including molecular interventions 2025. link 84 Chauvette V, Chaud GJ, Laurin C, Marzouk M, Kalavrouziotis D, Mohammadi S et al.. Long-term results of patients undergoing the Ross procedure after a previous aortic valve surgery. The Journal of thoracic and cardiovascular surgery 2025. link 85 Minami K, Kazawa M. Correlations between intraoperative and postoperative echocardiographic measurements in patients undergoing aortic bioprosthetic valve replacement: a prospective observational study. General thoracic and cardiovascular surgery 2025. link 86 Brand A, Hornig C, Crayen C, Hamann A, Martineck S, Leistner DM et al.. Medical graphics to improve patient understanding and anxiety in elderly and cognitively impaired patients scheduled for transcatheter aortic valve implantation (TAVI). Clinical research in cardiology : official journal of the German Cardiac Society 2025. link 87 Lehto J, Björn R, Halminen O, Linna M, Haukka J, Putaala J et al.. Quality of anticoagulation and outcomes after mechanical aortic valve replacement in patients with atrial fibrillation: a nationwide cohort study. European heart journal. Quality of care & clinical outcomes 2025. link 88 Hosseini Mohammadi NS, Tavakoli K, Taebi M, Zafari A, Riahi M, Molaei MM et al.. Comparative Prognostic Value of Risk Factors for Predicting Pacemaker Implantation After Transcatheter Aortic Valve Replacement: A Systematic Review and Network Meta-Analysis. The American journal of cardiology 2025. link 89 Chiabrando JG, Lombardi M, Seropian IM, Valle Raleigh JM, Vergallo R, Larribau M et al.. Chronic systemic glucocorticoid therapy is associated with increased risk of major vascular complications and cardiac tamponade after transcatheter aortic valve implantation: a systematic review and meta-analysis. Minerva cardiology and angiology 2024. link 90 Awad AK, Ahmed A, Mathew DM, Varghese KS, Mathew SM, Khaja S et al.. Minimally invasive, surgical, and transcatheter aortic valve replacement: A network meta-analysis. Journal of cardiology 2024. link 91 Kinoshita H, Yamamoto M, Adachi Y, Yamaguchi R, Takemura A. Fascia Iliaca Block Reduces Remifentanil Requirement in Conscious Sedation for Transcatheter Aortic Valve Implantation　- A Randomized Clinical Trial. Circulation journal : official journal of the Japanese Circulation Society 2024. link 92 Jia YY, Guo ZT, Zhang YP, Song JP. Development of a complex intervention to prevent complications in patients recovering at home after transcatheter aortic valve replacement by optimizing home-based cardiac rehabilitation processes: a Delphi study. Frontiers in public health 2024. link 93 Perez KA, Deppe DW, Filas A, Singh SA, Aikawa E. Multimodal Analytical Tools to Enhance Mechanistic Understanding of Aortic Valve Calcification. The American journal of pathology 2024. link 94 Kim M, Choi JH, Kim HK, Kim HL, Shin SH, Jang JY et al.. Effects of intensive blood pressure control on left ventricular hypertrophy in aortic valve disease. American heart journal 2024. link 95 Levine D, Patel P, Wang C, Pan C, Dong A, Leshnower B et al.. Valve-sparing root replacement versus composite valve graft root replacement: Analysis of more than 1500 patients from 2 aortic centers. The Journal of thoracic and cardiovascular surgery 2024. link 96 Hassler KR, Monaghan K, Green C, Yang B. How-I-Do-It: Aortic Annular Enlargement - Are the Nicks and Manouguian Obsolete?. Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual 2024. link 97 Cosma J, Russo A, Schino S, Muscoli S, Marchei M, DI Luozzo M et al.. Pacemaker dependency and conduction system recovery following transcatheter aortic valve implantation. Minerva cardiology and angiology 2024. link 98 Francica A, Benvegnù L, San Biagio L, Tropea I, Luciani GB, Faggian G et al.. Ten-year clinical and echocardiographic follow-up of third-generation biological prostheses in the aortic position. The Journal of thoracic and cardiovascular surgery 2024. link 99 Androshchuk V, Chehab O, Prendergast B, Rajani R, Patterson T, Redwood S. Computed tomography derived anatomical predictors of vascular access complications following transfemoral transcatheter aortic valve implantation: A systematic review. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2024. link 100 Beaver T, Bavaria JE, Griffith B, Svensson LG, Pibarot P, Borger MA et al.. Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. The Journal of thoracic and cardiovascular surgery 2024. link

Original source

[1]
Maternal, Valvular and Foetal Outcomes of Pregnancy Following Aortic Valve Replacement. — Khargi SDM, Grashuis P, Veen KM, Kluin J, Cornette JMJ, Johnson MR et al. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery (2026)
[2]
Calcific Aortic Valve Disease: Mechanism and Future Therapeutic Strategies. — Hwang G, Jo S, Kwon H, Kwon M, Ku I, Song JK et al. Cells (2026)
[3]
In vitro characterization of hemodynamics in bicuspid aortic valves: The impact of valve and ascending aortic morphologies. — Hattori K, Nakama N, Takada J, Nagao M, Goto Y, Niinami H et al. Magnetic resonance in medicine (2026)
[4]
Added Diagnostic Value of Electrophysiological Study in New Onset Left Bundle Branch Block After Transcatheter Aortic Valve Implantation. — Massoullié G, Souteyrand G, Ploux S, Combaret N, Mondoly P, Pereira B et al. The Canadian journal of cardiology (2026)
[5]
Right ventricular function assessment following transcatheter aortic valve implantation/replacement (TAVI/TAVR): a systematic review and meta-analysis comparing speckle tracking and conventional echocardiographic approaches. — Goudarzi E, Aghajani S, Ebrahimi N, Akarzadeh D, Javadi M, Layegh Mirhosseyni SS et al. Journal of echocardiography (2026)
[6]
Five-Year Results of Aortic Valve Replacement With a Novel Bioprosthesis: Real-World Data From a Large Multicenter Registry. — Onorati F, Geisler D, Theron A, Francica A, Caruso V, Mariani C et al. The Annals of thoracic surgery (2026)
[7]
Evaluating the Accessibility of Transcatheter and Surgical Aortic Valve Replacement Across the US Via Driving-Times. — Kapadia S, Shen M, Hanna J, Wheelock K, Pedroso AF, Vora A et al. The American journal of cardiology (2026)
[8]
Pathology-Independent Expansion of Indications for Rapid-Deployment Aortic Valve Replacement: Midterm Outcomes. — Bae SY, Kim KH, Sohn SH, Kang Y, Kim JS, Choi JW The Thoracic and cardiovascular surgeon (2026)
[9]
Antithrombotic Therapy Selection and Association With Clinical Outcomes Following Valve-in-Valve Transcatheter Aortic Valve Replacement. — D'Angelo J, Ueyama H, Patel K, Babaliaros V, Greenbaum A, Byku I et al. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2026)
[10]
Impact of Early Atrioventricular Nodal Blocker Use Post-Transcatheter Aortic Valve Replacement. — Edwards J, Carroll Z, Lovelace M, Mandel J, Carter L, Kline T Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2026)
[11]
Challenging the transcatheter-first paradigm: Redo surgical aortic valve replacement after previous transcatheter or surgical aortic valve replacement. — Fukuhara S, Ling C, Patel HJ, Hamilton BCS, Hawkins RB, Ailawadi G et al. The Journal of thoracic and cardiovascular surgery (2026)
[12]
Bicuspid and Unicuspid Aortic Valves: Development, Genetics, and Lifelong Management. — Shah AH, De Backer O The American journal of cardiology (2026)
[13]
Long-Term Impact of Mild Paravalvular Regurgitation After Transcatheter Aortic Valve Replacement: The OCEAN-TAVI Registry. — Watanabe Y, Yamamoto M, Hioki H, Saito M, Omiya J, Kito K et al. JACC. Cardiovascular interventions (2026)
[14]
Global, regional, and national burden of non-rheumatic calcific aortic valve disease, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. — Xie M, Qian X, Yan G, Chen L, Ma R, Xiao Y International journal of surgery (London, England) (2026)
[15]
Explant of a 21-mm homograft with redo aortic root replacement with a 25-mm bioprosthesis. — McCullough K, Klopfer V, Ohira S Multimedia manual of cardiothoracic surgery : MMCTS (2026)
[16]
Risk of delayed atrioventricular block in patients without procedural conduction disturbances during transcatheter aortic valve replacement. — Fischer Q, Nombela-Franco L, Muntané-Carol G, Veiga G, Regueiro A, Nazif T et al. Heart rhythm (2026)
[17]
Children are Less Likely Than Adults to Develop Complete Heart Block Following TAVR. — Newlon CA, Niu MC, Binka E, Boucek DM, Ou Z, Etheridge SP et al. Pediatric cardiology (2026)
[18]
Pulmonary valve repair at the time of the Ross procedure: A safe and durable strategy to address postimplantation aortic regurgitation. — Chauvette V, Bouhout I, Laurin C, Notenboom ML, Williams EE, Cartier R et al. The Journal of thoracic and cardiovascular surgery (2026)
[19]
Bicuspidization of the unicuspid aortic valve using the pericardial advancement technique. — Munakata H, Okita Y Asian cardiovascular & thoracic annals (2026)
[20]
Association of GLP-1 Receptor Agonist and SGLT2 Inhibitor With Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement. — Fahoury AM, Kamel-Abusalha L, Didier AJ, Wunderly K, Sarrouj S, Issa R et al. The American journal of cardiology (2026)
[21]
Outcomes of moderate mixed aortic valve stenosis and regurgitation. — Lopez Santi P, Bernard J, Chua A, Laenens D, Powers A, Abdoun K et al. European heart journal (2026)
[22]
Outcomes of Transcatheter Aortic Valve Replacement in Patients With Moderate Mixed Aortic Valve Disease. — Tang Y, Qiao XC, Yan MY, Yin Y, Li WY, Zhang Y et al. The American journal of cardiology (2026)
[23]
Transcatheter Aortic Valve-in-Valve Implantation for Failing Stentless Bioprosthetic Aortic Valves: An International Multicentre Retrospective Analysis. — Rayner C, Paleri S, Satpal A, Tomii D, Pilgrim T, Codner P et al. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2026)
[24]
Sutureless aortic valves: timing, technique, and evidence. — Patel SK, Hassan SMA, Dhingra NK, Verma R, Cohen G Current opinion in cardiology (2026)
[25]
CT Angiography of the Native Aortic Valve and Paravalvular Disease: From Imaging to Decision-Making. — Vaz A, Araújo LR, Mangolini VI, de Brito Filho MT, Cronemberger PJLA, Tavares VS et al. Academic radiology (2026)
[26]
Comparing TA-TAVR and SAVR in severe aortic regurgitation: outcomes and valve haemodynamics. — He Z, Cai D, Li M, Feng Z, Liang C, Ma R et al. Open heart (2026)
[27]
A Streamline Strategy for Indication and Length of Telemetry Monitoring After TAVR. — Fournier A, Robert P, Lattuca B, Duflos C, Duroyon MM, Macia JC et al. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2026)
[28]
Predictors and outcomes of high ventricular pacing burden post transcatheter aortic valve replacement: 5 years of follow-up. — Goldenberg GR, Barsheshet A, Erez A, Tal S, Skalsky K, Shechter A et al. International journal of cardiology (2026)
[29]
Full Heparin Reversal With Protamine After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. — Silva JPMRJ, Nogueira BV, Mussolini MCB, Bisneto OIM, Gomes WF The American journal of cardiology (2026)
[30]
Impact of early PR interval prolongation after transcatheter aortic valve Implantation (TAVI) on the onset of high-grade conduction disturbances. — Massoullie G, Bouchant-Pioche M, Pereira B, Boudias A, Souteyrand G, Catalan PA et al. Clinical research in cardiology : official journal of the German Cardiac Society (2026)
[31]
Transcatheter aortic valve thrombosis. — Jacobsen MR, Overduin DC, Sørensen R, Andreotti F, Schulte C, Huber K et al. EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology (2026)
[32]
Factors Predicting Early Outcome of Aortic Valve Neocuspidization in the Pediatric Population. — Sivalingam S, Haranal MY, See WS Pediatric cardiology (2026)
[33]
Systematic Dental Screening Before Transcatheter Aortic Valve Replacement: A Call to Action! — Amoroso G, Mellema EC Cardiology in review (2026)
[34]
Caldesmon-1-mediated actin dynamics is essential for osteogenic differentiation of aortic valve interstitial cells. — Komoda M, Sakaue T, Nakao Y, Sakamoto H, Fukunishi T, Higaki T et al. Scientific reports (2026)
[35]
Ross operation in current practice of aortic surgeons. — Doi A Asian cardiovascular & thoracic annals (2026)
[36]
Minithoracotomy Versus Sternotomy for Aortic Valve Replacement: Outcomes from a Latin American Comparative Study. — Ríos-Ortega JC, Quispe-Vizcarra C, Sisniegas-Razón J, Conde-Moncada R, Talledo-Paredes L, Polo-Lecca G et al. Interdisciplinary cardiovascular and thoracic surgery (2026)
[37]
Mastering aortic valve repair: A standardized step-by-step teaching approach of remodeling root replacement with external ring annuloplasty. — Saiydoun G, Saade S, Alghamdi M, Youssefi P, Demine B, Leprince P et al. The Journal of thoracic and cardiovascular surgery (2026)
[38]
Repair of Asymmetric Bicuspid Aortic Valve Using Tricuspidation with CardioCel. — Urbanski PP, Irimie VP Interdisciplinary cardiovascular and thoracic surgery (2026)
[39]
Incidence and associates of aortic valve replacement in people with or without type 2 diabetes: The Fremantle diabetes study phase II. — Davis TME, Davis WA Diabetic medicine : a journal of the British Diabetic Association (2026)
[40]
Prevalence and clinical significance of masquerading bundle branch block in patients undergoing transcatheter aortic valve replacement: Insights from a single-center registry. — Avidan Y, Sliman H, Khoury R, Bashir S, Weizman B, Tarabih M et al. Heart rhythm (2026)
[41]
Comparison of Long-Term Performance of Porcine versus Pericardial Bioprostheses. — Anselmi A, Daniel M, Aymami M, Chabanne C, Rosier S, Mancini J et al. The Thoracic and cardiovascular surgeon (2026)
[42]
Innovations in robotic aortic valve surgery. — Darehzereshki A, Wei L, Badhwar V Current opinion in cardiology (2026)
[43]
Aortic remodeling and pulmonary autograft performance over 2 decades after the Ross procedure in the pediatric and young adult population. — Salem M, Yörüker U, Valeske K, Thul J, Müller M, Jux C et al. The Journal of thoracic and cardiovascular surgery (2026)
[44]
Mechanical behaviors of an asymmetric transcatheter prosthetic valve in bicuspid aortic valve. — Shen X, Yao H, He Z, Xu Y, Chen J, Gao J et al. Biomechanics and modeling in mechanobiology (2026)
[45]
Aortic valve morphology rather than aortic valve function, aortic dilatation, and age interferes with ascending aortic structural and biomechanical properties. — Federspiel JM, Reil JC, Schmidt PH, Teping P, Ramsthaler F, Schwab T et al. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology (2026)
[46]
Analysis of aortic valve prostheses using advanced cardiovascular imaging-a patient-specific reversed translational approach. — Grefen L, Herz C, Flexeder J, Grab M, Mueller C, Peterss S et al. Scientific reports (2026)
[47]
Risk Stratification in Left Bundle Branch Block After Transcatheter Aortic Valve Implantation: A Multicenter ECG Algorithm Study. — Badertscher P, Serban T, Massoullie G, Eschalier R, Rivard L, Portelance D et al. JACC. Clinical electrophysiology (2026)
[48]
Predictors for Length of Stay after Surgical Aortic Valve Replacement. — Demal TJ, Arndt N, Bhadra OD, Ludwig S, Grundmann D, Voigtlaender-Buschmann L et al. The Thoracic and cardiovascular surgeon (2026)
[49]
Healthcare burden of mixed aortic valve stenosis and insufficiency disease. — Sultan I, Ryan M, Gunnarsson C, Marfo G, Vallabhajosyula P Journal of medical economics (2026)
[50]
Lactate Dehydrogenase Levels after Aortic Valve Replacement: What Do They Tell Us? — Rings L, Mavrova-Risteska L, Haeussler A, Ntinopoulos V, Tanadini M, Rodriguez Cetina Biefer H et al. The Thoracic and cardiovascular surgeon (2026)
[51]
Quantified calcification in rat aortic valves isolated with the sinus of Valsalva coordinates with calciprotein particles formation. — Morikane S, Ishida K, Ashizawa N, Taniguchi T, Matsubayashi M, Kurita N et al. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology (2026)
[52]
Impact of Body Mass Index on the Initial Phase of a Minimally Invasive Aortic Valve Program. — Ewais E, Bauer N, Schlömicher M, Bechtel M, Moustafine V, Hamdani N et al. The Thoracic and cardiovascular surgeon (2026)
[53]
Impact of Anticoagulation on Long-Term Bioprosthesis Durability After Transcatheter Aortic Valve Replacement. — Trimaille A, Hernando Del Portillo J, Giuliani C, Vidal-Cales P, Salaun E, Avvedimento M et al. The Canadian journal of cardiology (2026)
[54]
Impact of pulmonary-artery-to-aorta ratio on clinical outcomes in patients undergoing transcatheter aortic valve implantation: A retrospective study. — Wang Y, Shen R, Liu Y Science progress (2026)
[55]
Current evidence of unicuspid aortic valve in young adults: A systematic review and metanalysis. — Carbone A, Ferrara F, Bottino R, Russo V, Rega S, Limongelli G et al. Current problems in cardiology (2025)
[56]
Machine-learning versus traditional methods for prediction of all-cause mortality after transcatheter aortic valve implantation: a systematic review and meta-analysis. — Zaka A, Mustafiz C, Mutahar D, Sinhal S, Gorcilov J, Muston B et al. Open heart (2025)
[57]
Transcatheter aortic valve implantation vs. surgery for failed bioprosthesis: a meta-analysis of over 20 000 patients. — Comentale G, Ahmadi-Hadad A, Moldon HJ, Carbone A, Manzo R, Franzone A et al. Journal of cardiovascular medicine (Hagerstown, Md.) (2025)
[58]
Clinical validation of the 2021 European Society of Cardiology guidelines on preexisting right bundle branch block in patients undergoing transcatheter aortic valve implantation. — Salis M, Badertscher P, Papa A, Knecht S, Serban T, Nestelberger T et al. Heart rhythm (2025)
[59]
The Utility of Cardiac Computed Tomographic Angiography in Differentiating Between Papillary Fibroelastoma, Infective Endocarditis, and Degeneration of the Aortic Valve. — Hsu WC, Kamona A, Oncel D, Fishman EK, Lin CT Journal of computer assisted tomography (2025)
[60]
Prognostic utility of dynamic changes in epicardial adipose tissue in patients undergoing transcatheter aortic valve replacement. — Lin S, Zhang Y, Wang S, Ding X, Wu J, Wang X et al. International journal of cardiology (2025)
[61]
Risk Factors for Reduced Long-Term Survival Following Isolated Surgical Aortic Valve Replacement in Different Age Groups. — Groenewoud R, Peng D, Gottschalk BH, Rokui S, Gauthier C, Ye J The Canadian journal of cardiology (2025)
[62]
Aortic Valve Replacement with Single-Strip Autologous Pericardium. — Dilawar I, Rachmat J, Puruhito I, Alwi I, Sastroasmoro S, Suhendro S et al. The Thoracic and cardiovascular surgeon (2025)
[63]
VARC-3 defined outcome of valve-in-valve transcatheter aortic valve implantation in stentless compared with stented aortic bioprostheses. — Steul JH, Abdel-Wahab M, Stankowski T, Haussig S, Woitek FJ, Gasior T et al. Clinical research in cardiology : official journal of the German Cardiac Society (2025)
[64]
Acquired Thrombocytopenia in Contemporary Transcatheter Aortic Valve Prosthesis. — Petrov A, Taghizadeh-Waghefi A, Diab AH, Breuer L, Arzt S, Matschke KE et al. The Thoracic and cardiovascular surgeon (2025)
[65]
Integrated Severity Staging of Paravalvular Regurgitation After Transcatheter Aortic Valve Implantation Using Echocardiographic and Hemodynamic Assessment. — Viscusi MM, Mistrulli R, Corradetti S, De Oliveira EK, Mahendiran T, Storozhenko T et al. The American journal of cardiology (2025)
[66]
Prediction model for leaflet thrombosis in patients undergoing transcatheter aortic valve implantation: the EFFORT study. — Steiner-Gager GM, Rogozarski J, Kronberger C, Dizdarevic AM, Quehenberger P, Schernthaner R et al. Clinical research in cardiology : official journal of the German Cardiac Society (2025)
[67]
Aortic valve degeneration after valve-sparing root replacement in patients with bicuspid aortopathy or connective tissue disorder. — Lau C, Ram E, Harik L, Soletti G, Leith J, Mack CA et al. The Journal of thoracic and cardiovascular surgery (2025)
[68]
The contributions of increased reactive oxygen species and inflammatory macrophages to the development of aortic valve calcification. — Salemizadehparizi F, Huang P, Chen MH, Mahler GJ Free radical biology & medicine (2025)
[69]
Aortic Annular Enlargement vs Isolated Aortic Valve Replacement in Patients With Matched Annulus. — Makkinejad A, Monaghan K, Chen SA, Wu X, Ling C, Kim K et al. The Annals of thoracic surgery (2025)
[70]
Hemodynamics and Diastolic Function after Native Aortic Valve Preserving vs. Replacing Surgery. — Holst T, Hua X, Sinning C, Waschki B, Reichenspurner H, Girdauskas E et al. The Thoracic and cardiovascular surgeon (2025)
[71]
ECG, clinical and novel CT-imaging predictors of necessary pacemaker implantation after transfemoral aortic valve replacement. — Klambauer K, Puhr-Westerheide D, Fabritius MP, Kunz WG, Dinkel J, Schmid-Tannwald C et al. European journal of radiology (2025)
[72]
Impact of the grade and jet-flow direction of residual aortic regurgitation after valve-sparing root replacement. — Kim H, Lee OJ, Lee JH, Kim YJ, Chung SR, Park TK et al. The Journal of thoracic and cardiovascular surgery (2025)
[73]
Contribution margins and utilization of transcatheter aortic valve replacement versus surgical aortic valve replacement in the Medicare population. — Reddy KP, Shultz K, Eberly LA, Khatana SAM, Fanaroff AC, Kumbhani DJ et al. American heart journal (2025)
[74]
Robotic-Assisted Aortic Valve Replacement and Coronary Artery Bypass Grafting. — Badhwar V, Raikar GV, Darehzereshki A, Mehaffey JH, Daggubati R, Wei LM The Annals of thoracic surgery (2025)
[75]
Reverse-U Aortotomy (Kırali Incision) for Aortic Valvular Interventions. — Ozgur MM, Hancer H, Yigit F, Aksut M, Ozer T, Altas O et al. The Thoracic and cardiovascular surgeon (2025)
[76]
Atherosclerosis, calcific aortic valve disease and mitral annular calcification: same or different? — Hafiane A, Pisaturo A, Favari E, Bortnick AE International journal of cardiology (2025)
[77]
Surgical versus transcatheter aortic valve replacement in low-risk Medicare beneficiaries. — Mehaffey JH, Kawsara M, Jagadeesan V, Hayanga JWA, Chauhan D, Wei L et al. The Journal of thoracic and cardiovascular surgery (2025)
[78]
Aortic Valve Replacement and Repair With or Without Concomitant Ascending Aorta Replacement: Impact on Outcomes: A Systematic Review. — Zhang C, Butt S, Kashif H, Rowe C, Harky A, Zeinah M Cardiology in review (2025)
[79]
The early and medium-term results of the Ross procedure in pediatric patients. — Bakhshaliyev S, Arslanoğlu E, Aliyev B, Çitoğlu G, Altunyuva K, Demir I et al. Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology (2025)
[80]
Aortic valve cusp size and shape in dilated trileaflet aortic roots. — Jelenc M, Jelenc B, Habjan S, Fries P, Giebels C, Foley T et al. The Journal of thoracic and cardiovascular surgery (2025)
[81]
Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic Valve Disease. — Benkhoff M, Barcik M, Mourikis P, Dahlmanns J, Kahmann P, Wollnitzke P et al. Circulation (2025)
[82]
Impact of transcatheter aortic valve replacement use ratio on outcomes in patients with aortic valve disease. — Marghitu T, Roberts SH, He J, Kouchoukos N, Kachroo P, Roberts H et al. The Journal of thoracic and cardiovascular surgery (2025)
[83]
Real-world outcomes and management considerations following surgical aortic valve replacement with the Trifecta valve. — Gutfinger D, Sultan I, Ailawadi G, Ramzy D, Kaneko T, Yu Y et al. Cardiovascular revascularization medicine : including molecular interventions (2025)
[84]
Long-term results of patients undergoing the Ross procedure after a previous aortic valve surgery. — Chauvette V, Chaud GJ, Laurin C, Marzouk M, Kalavrouziotis D, Mohammadi S et al. The Journal of thoracic and cardiovascular surgery (2025)
[85]
Correlations between intraoperative and postoperative echocardiographic measurements in patients undergoing aortic bioprosthetic valve replacement: a prospective observational study. — Minami K, Kazawa M General thoracic and cardiovascular surgery (2025)
[86]
Medical graphics to improve patient understanding and anxiety in elderly and cognitively impaired patients scheduled for transcatheter aortic valve implantation (TAVI). — Brand A, Hornig C, Crayen C, Hamann A, Martineck S, Leistner DM et al. Clinical research in cardiology : official journal of the German Cardiac Society (2025)
[87]
Quality of anticoagulation and outcomes after mechanical aortic valve replacement in patients with atrial fibrillation: a nationwide cohort study. — Lehto J, Björn R, Halminen O, Linna M, Haukka J, Putaala J et al. European heart journal. Quality of care & clinical outcomes (2025)
[88]
Comparative Prognostic Value of Risk Factors for Predicting Pacemaker Implantation After Transcatheter Aortic Valve Replacement: A Systematic Review and Network Meta-Analysis. — Hosseini Mohammadi NS, Tavakoli K, Taebi M, Zafari A, Riahi M, Molaei MM et al. The American journal of cardiology (2025)
[89]
Chronic systemic glucocorticoid therapy is associated with increased risk of major vascular complications and cardiac tamponade after transcatheter aortic valve implantation: a systematic review and meta-analysis. — Chiabrando JG, Lombardi M, Seropian IM, Valle Raleigh JM, Vergallo R, Larribau M et al. Minerva cardiology and angiology (2024)
[90]
Minimally invasive, surgical, and transcatheter aortic valve replacement: A network meta-analysis. — Awad AK, Ahmed A, Mathew DM, Varghese KS, Mathew SM, Khaja S et al. Journal of cardiology (2024)
[91]
Fascia Iliaca Block Reduces Remifentanil Requirement in Conscious Sedation for Transcatheter Aortic Valve Implantation　- A Randomized Clinical Trial. — Kinoshita H, Yamamoto M, Adachi Y, Yamaguchi R, Takemura A Circulation journal : official journal of the Japanese Circulation Society (2024)
[92]
Development of a complex intervention to prevent complications in patients recovering at home after transcatheter aortic valve replacement by optimizing home-based cardiac rehabilitation processes: a Delphi study. — Jia YY, Guo ZT, Zhang YP, Song JP Frontiers in public health (2024)
[93]
Multimodal Analytical Tools to Enhance Mechanistic Understanding of Aortic Valve Calcification. — Perez KA, Deppe DW, Filas A, Singh SA, Aikawa E The American journal of pathology (2024)
[94]
Effects of intensive blood pressure control on left ventricular hypertrophy in aortic valve disease. — Kim M, Choi JH, Kim HK, Kim HL, Shin SH, Jang JY et al. American heart journal (2024)
[95]
Valve-sparing root replacement versus composite valve graft root replacement: Analysis of more than 1500 patients from 2 aortic centers. — Levine D, Patel P, Wang C, Pan C, Dong A, Leshnower B et al. The Journal of thoracic and cardiovascular surgery (2024)
[96]
How-I-Do-It: Aortic Annular Enlargement - Are the Nicks and Manouguian Obsolete? — Hassler KR, Monaghan K, Green C, Yang B Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual (2024)
[97]
Pacemaker dependency and conduction system recovery following transcatheter aortic valve implantation. — Cosma J, Russo A, Schino S, Muscoli S, Marchei M, DI Luozzo M et al. Minerva cardiology and angiology (2024)
[98]
Ten-year clinical and echocardiographic follow-up of third-generation biological prostheses in the aortic position. — Francica A, Benvegnù L, San Biagio L, Tropea I, Luciani GB, Faggian G et al. The Journal of thoracic and cardiovascular surgery (2024)
[99]
Computed tomography derived anatomical predictors of vascular access complications following transfemoral transcatheter aortic valve implantation: A systematic review. — Androshchuk V, Chehab O, Prendergast B, Rajani R, Patterson T, Redwood S Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2024)
[100]
Seven-year outcomes following aortic valve replacement with a novel tissue bioprosthesis. — Beaver T, Bavaria JE, Griffith B, Svensson LG, Pibarot P, Borger MA et al. The Journal of thoracic and cardiovascular surgery (2024)

Share:Twitter Reddit LinkedIn